Does DABRAFENIB Cause Respiratory tract infection? 17 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 17 reports of Respiratory tract infection have been filed in association with DABRAFENIB (Tafinlar). This represents 0.1% of all adverse event reports for DABRAFENIB.
17
Reports of Respiratory tract infection with DABRAFENIB
0.1%
of all DABRAFENIB reports
2
Deaths
10
Hospitalizations
How Dangerous Is Respiratory tract infection From DABRAFENIB?
Of the 17 reports, 2 (11.8%) resulted in death, 10 (58.8%) required hospitalization.
Is Respiratory tract infection Listed in the Official Label?
Yes, Respiratory tract infection is listed as a known adverse reaction in the official FDA drug label for DABRAFENIB.
What Other Side Effects Does DABRAFENIB Cause?
Pyrexia (3,788)
Death (2,740)
Malignant neoplasm progression (1,667)
Fatigue (1,328)
Nausea (1,300)
Chills (1,235)
Rash (1,078)
Vomiting (907)
Diarrhoea (901)
Headache (697)
What Other Drugs Cause Respiratory tract infection?
RITUXIMAB (1,058)
PREDNISONE (1,051)
OMALIZUMAB (927)
ADALIMUMAB (913)
METHOTREXATE (895)
ETANERCEPT (848)
HUMAN IMMUNOGLOBULIN G (764)
LENALIDOMIDE (731)
DEXAMETHASONE (684)
ALBUTEROL (601)
Which DABRAFENIB Alternatives Have Lower Respiratory tract infection Risk?
DABRAFENIB vs DABRAFENIB\TRAMETINIB
DABRAFENIB vs DACARBAZINE
DABRAFENIB vs DACLATASVIR
DABRAFENIB vs DACLIZUMAB
DABRAFENIB vs DACOMITINIB